Price
$11.91-4.87%Social Signal Score
Analyst Ratings
1 analystRevenue
$2.20B-84.98%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Christoph Jurecka
- Sector
- Financial Services
- Industry
- Insurance - Reinsurance
- Employees
- 43,982
- Beta
- 0.34
- Country
- DE
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 0.54
Financials
Revenue
$2.20B-85.0%Net Income
$1.73B+252.7%EBITDA
$2.46B+89.5%Free Cash Flow
—EPS (diluted)
$0.28-20.0%Shares Outstanding (diluted)
6.26B+346.2%Operating Expenses
$0.00Cash & Debt
—Return of Capital
$0.00Dividend per Share
$0.56Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $66.57B | $5.88B | $0.90 |
| 2024 | $42.31B | $5.68B | $4.26 |
| 2023 | $39.68B | $4.61B | $3.39 |
| 2022 | $39.71B | $5.31B | $3.81 |
| 2021 | $64.46B | $2.93B | $2.09 |
| 2020 | $58.64B | $1.21B | $0.86 |
| 2019 | $58.08B | $2.72B | $1.90 |
| 2018 | $52.07B | $2.31B | $1.55 |
| 2017 | $55.82B | $375.00M | $0.24 |
| 2016 | $55.69B | $2.58B | $1.61 |
| 2015 | $56.37B | $3.11B | $1.87 |
| 2014 | $56.36B | $3.15B | $1.83 |
| 2013 | $57.49B | $3.30B | $1.85 |
| 2012 | $59.85B | $3.19B | $1.79 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from MURGY's reported EPS growth of -5.2% a year over 13 years.
- EPS in 5 years
- $0.69
- Implied price
- $8.32
- Return from $12.62
- -8.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $4.14 — -67.2% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 8 | 10 | 12 | 14 | 16 |
|---|---|---|---|---|---|
| -15.2% | -24.1% | -20.6% | -17.7% | -15.1% | -12.8% |
| -10.2% | -19.6% | -16.0% | -12.8% | -10.1% | -7.7% |
| -5.2% | -15.2% | -11.3% | -8.0% | -5.1% | -2.5% |
| -0.2% | -10.7% | -6.6% | -3.1% | -0.1% | 2.6% |
| 4.8% | -6.2% | -1.9% | 1.7% | 4.9% | 7.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100+25.00%Social Signal Score
Mentions (6)
- Newsseekingalpha.com·16h ago·Neutral
Munich RE: A High-Quality Reinsurer Trading Near Fair Value Following Q3 Earnings Munich RE remains a Hold: its 2.1x book valuation looks fair, reflecting business quality and limiting upside. Strong underwriting and higher investment returns lifted 2026 net income guidance to €6.6 billion, despite weaker Q3 earnings. MURGY's 4.5% forward dividend yield and capital returns above 80% of earnings remain attractive, supported by a 301% solvency ratio.
View source ↗ - Newszacks.com·3d ago·Positive
Can Munich Re Sustain Growth as Reinsurance Pricing Moderates? Munich Re's disciplined underwriting, strong capital position and rising profit targets support its growth outlook despite moderating reinsurance pricing.
View source ↗ - Newsseekingalpha.com·6d ago·Neutral
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Q3 2026 Earnings Call Transcript Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München ( MURGY ) Q3 2026 Earnings Call November 12, 2026 5:00 AM EST Company Participants Christian Becker-Hussong - Head of Investor & Rating Agency Relations Andrew Buchanan - CFO & Member of Management Board Conference Call Participants Andrew Baker - Goldman Sachs Group, Inc., Research Division Shanti Kang - BofA Secur…
View source ↗ - Newszacks.com·46d ago·Negative
MURGY vs. AXAHY: Which Stock Is the Better Value Option? Investors interested in Insurance - Multi line stocks are likely familiar with M?nchener R?ckversicherungs-Gesellschaft (MURGY) and Axa Sa (AXAHY). But which of these two stocks offers value investors a better bang for their buck right now?
View source ↗ - Newsseekingalpha.com·106d ago·Neutral
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Q2 2026 Earnings Call Transcript Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Q2 2026 Earnings Call Transcript
View source ↗ - Newsseekingalpha.com·106d ago·Neutral
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Q2 2026 Earnings Call Prepared Remarks Transcript Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (MURGY) Q2 2026 Earnings Call Prepared Remarks Transcript
View source ↗
Earnings
Thu, Feb 25(in 3 months)
Consensus estimate $0.20 per share
Typical surprise +18.5% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Nov 12$0.32 vs $0.27beat
- Fri, Aug 7$0.41 vs $0.30beat
- Tue, May 12$0.31 vs $0.32miss
- Thu, Feb 26$0.17 vs $0.17beat
- Tue, Nov 11$0.36 vs $0.34beat
- Fri, Aug 8$0.36 vs $0.30beat
Estimates and results for MURGY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Congress trades
- Daniel Goldmanhouse · NY10 · disclosed Aug 13, 2023 (34d later)Sell$15,001 - $50,000
- John Henry Rutherfordhouse · FL04 · disclosed Apr 19, 2022 (34d later)Sell$1,001 - $15,000
- John Henry Rutherfordhouse · FL04 · disclosed Jan 2, 2019 (30d later)Buy$1,001 - $15,000
- John Henry Rutherfordhouse · FL04 · disclosed Aug 20, 2018 (405d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
